Northern Trust
KYTX icon

Northern Trust’s Kyverna Therapeutics KYTX Stock Holding History

Northern Trust’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81M Buy
315,354
+237,312
+304% +$2.11M ﹤0.01% 2938
2026
Q1 		$674K Buy
78,042
+26,470
+51% +$221K ﹤0.01% 3494
2025
Q4 		$485K Sell
51,572
-106
-0.2% -$787 ﹤0.01% 3666
2025
Q3 		$310K Hold
51,678
– – ﹤0.01% 3817
2025
Q2 		$159K Sell
51,678
-139,986
-73% -$346K ﹤0.01% 4003
2025
Q1 		$370K Sell
191,664
-4,030
-2% -$11.9K ﹤0.01% 3693
2024
Q4 		$732K Buy
195,694
+61,757
+46% +$296K ﹤0.01% 3518
2024
Q3 		$655K Buy
133,937
+93,447
+231% +$720K ﹤0.01% 3495
2024
Q2 		$304K Buy
40,490
+11,697
+41% +$179K ﹤0.01% 3695
2024
Q1 		$715K Buy
+28,793
New +$803K ﹤0.01% 3437

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Northern Trust's KYTX Position: Q2 2026 in Review

Northern Trust increased its Kyverna Therapeutics (KYTX) stake by 304% in Q2 2026, buying an estimated $2.11M and bringing the position to 315,354 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

Northern Trust first reported a position in KYTX in Q1 2024 and has held it in 10 quarters since. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Northern Trust held 315,354 shares of Kyverna Therapeutics worth $2.81M as of Q2 2026.
  • Northern Trust bought 237,312 Kyverna Therapeutics shares in Q2 2026, an estimated $2.11M.
  • Kyverna Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2938 holding.
  • Northern Trust first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.